European stocks, U.S. Futures lose momentum


File – This September 2020 photo, provided by Johnson & Johnson, shows a single-dose COVID-19 vaccine being developed by the company.

A.P.


European stocks held lower on Tuesday, with traders losing momentum after halting key coronavirus trials waiting for earnings from some of the world’s leading banks.

Stocks Europe 600 SXXP, up 0.7% on Monday
-0.11%
Weakened by 0.5%.

German DAX DAX,
-0.17%,
French CAC 40 PX1,
-0.28%
And UK FTSE 100 UKX,
-0.23%
Even in the initial proceedings, there was panic.

U.S. stock S.P.X.
+ 1.64%
Tech-Heavy Nasdaq Composite CMP Also, the light exploded high Monday on small news during the Columbus Day holiday,
+ 2.55%
The third-closest position in history accounts for 2.6%. But the futures ES00,
-0.27%

NQ00,
+ 0.25%
Johnson and Johnson were as low as JNJ,
+ 0.57%
The trial of the coronavirus vaccine was suspended on Monday night after an unexplained illness. Stopping trials like this is not uncommon for drug makers, and yet stopping is not a more serious clinical hold.

The third quarter earnings season will begin on Tuesday with the results of JPMorgan Chase JPM,
+ 1.22%
And City Group C,
+ 2.11%,
As well as Johnson’s and Johnson’s.

Thursday, meanwhile, is the UK’s self-imposed date for reaching a trade agreement with the European Union. The current configuration lasts until the end of the year. UK figures show the unemployment rate rose to 4.5 in the three months to late August. to%, which was higher than expected, but masks expecting one big bounce after another once the Furlo program ends in late October.

From stocks on the move, Morphosis MOR,
-9.72%

Bloom,
+ 2.01%
Dual-listed biopharmaceuticals said the stock fell 9 percent as it sold shares 325 million worth of convertible bonds.

Rolls Royce R.R.,
-3.23%
The stock fell 8% on the second day of sharp losses to troubled engine makers after nearly doubling in value last week.

Rolls Royce customer, Airbus AIR,
-3.04%,
JPMorgan dropped 3% after being downgraded to less weight than the hold at Kazenov. The broker cited a more cautious view on air travel and airline profitability, which will see it reduce its vote on deliveries by 10% next year.

SSE SSE,
+ 3.73%
Shares rose 5% after an agreement was reached to sell its 50% stake in the energy fund-to-waste venture at 995 million in an infrastructure fund run by First Centurion Investors.

.